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Abstract
Schlemm’s canal is an important structure of the conventional aqueous humor outflow pathway and is critically involved in
regulating the intraocular pressure. In this study, we report a novel finding that prospero homeobox protein 1 (Prox-1), the
master control gene for lymphatic development, is expressed in Schlemm’s canal. Moreover, we provide a novel in vivo
method of visualizing Schlemm’s canal using a transgenic mouse model of Prox-1-green fluorescent protein (GFP). The
anatomical location of Prox-1
+ Schlemm’s canal was further confirmed by in vivo gonioscopic examination and ex vivo
immunohistochemical analysis. Additionally, we show that the Schlemm’s canal is distinguishable from typical lymphatic
vessels by lack of lymphatic vessel endothelial hyaluronan receptor (LYVE-1) expression and absence of apparent sprouting
reaction when inflammatory lymphangiogenesis occurred in the cornea. Taken together, our findings offer new insights into
Schlemm’s canal and provide a new experimental model for live imaging of this critical structure to help further our
understanding of the aqueous humor outflow. This may lead to new avenues toward the development of novel therapeutic
intervention for relevant diseases, most notably glaucoma.
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Introduction
Schlemm’s canal is a circumferential channel located at the
iridocorneal angle in the ocular anterior chamber. It is part of the
conventional aqueous humor outflow system of the anterior
chamber, which accounts for 70–90% of the total aqueous humor
that drains out of the eye. The endothelial cell lining of Schlemm’s
canal is one of the primary sites of resistance to aqueous humor
drainage and is a major determinant of intraocular pressure [1].
Intraocular pressure when elevated can often lead to glaucoma, a
disease affecting approximately 60 million people worldwide and is
the second leading cause of blindness globally [2]. However, the
particular contribution and exact mechanisms by which this
continuous endothelium monolayer of Schlemm’s canal resists
aqueous humor outflow still remain largely unclear in both normal
and glaucomatous eyes. It is therefore essential to enhance our
knowledge on this important structure, which is a crucial
prerequisite for developing new therapeutic strategies.
The cellular features and specialized functions of the canal’s
endothelium have recently been speculated as being both
lymphatic and blood vascular in nature [3]. It was reported
earlier that the Schlemm’s canal endothelia are derived from a
vascular origin and retain some properties of blood vessels [4,5].
Similarly, it is reported that the endothelial cell origins of the
lymphatic vessels stem from the venous vasculature, and the
transcription factor, prospero-related homeobox 1 (Prox-1), is
largely responsible for the induction of lymphatic endothelial cell
phenotype during development [6,7]. Interestingly, there has been
recent evidence to suggest that ocular lymphatics contribute to
drainage of aqueous humor from the eye [8,9,10]. However, the
physical and physiological relationship between Schlemm’s canal
and the lymphatic system has yet to be thoroughly assessed. To
date, there has been no report linking Prox-1 to the Schlemm’s
canal.
Lymphatic research has progressed rapidly in recent years and
the importance of the lymphatic system is now well-recognized in
health and disease [11,12]. The lymphatic system is comprised of
an extensive network of vessels that penetrates through most
tissues of the body and carries out important functions including
tissue fluid homeostasis, immune surveillance, as well as fat
absorption. Since a large portion of the fluids leaked out of the
blood capillaries in the peripheral tissues are returned back to the
blood circulation via the lymphatic system, lymphatic dysfunction
can lead to drainage disorders such as tissue swelling or
lymphedema. Prox-1, the master control gene of lymphatic
development, along with several other lymphatic endothelial cell
markers, such as lymphatic vessel endothelial hyaluronic acid
receptor-1 (LYVE-1) and vascular endothelial growth factor-3
(VEGFR-3), have been extensively used in lymphatic research to
allow for identification and exploration into the active growth of
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In this study, we performed mouse live imaging using our newly
developed advanced imaging system and a transgenic mouse
model of Prox-1-green fluorescent protein (GFP) [15,16]. The
expression of GFP under the Prox-1 promoter in the transgenic
mice allowed for direct and convenient visualization of lymphatic
vasculatures in vivo. In doing so, we discovered that besides limbal
lymphatics, Prox-1 was expressed on a previously unidentified
structure at the iridocorneal angle, which was Schlemm’s canal.
The anatomical location of the Prox-1
+ Schlemm’s canal was
further confirmed by in vivo gonioscopic examination as well as ex
vivo immunohistochemical analysis. Moreover, we found that the
highly recognizable Prox-1
+ Schlemm’s canal was distinguishable
from typical lymphatic vessels by lack of LYVE-1 expression and
absence of apparent sprouting reaction when inflammatory
lymphangiogenesis was induced from limbal lymphatics.
Methods
Mice and anesthesia
Transgenic Prox-1-GFP mice of FVB/N or C57BL/6 back-
ground and wildtype mice (adult mice $ 12 weeks of age and
postnatal mice of 3 weeks of age) were used in the experiments
[15]. The Prox1-GFP BAC construct was created by inserting the
GFP-coding sequences under the Prox-1 promoter in a Prox-1-
harboring BAC through homologous recombination by the
GENSAT researchers [17]. This BAC contains a mouse genomic
contig harboring all regulatory elements for Prox-1 expression and
it has been shown that the Prox-1-GFP mice faithfully recapitulate
Prox-1 expression in lymphatic vessels with no morphologic
alternation [15]. All mice were treated according to ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research, and all protocols were approved by the Animal Care
and Use Committee of University of Southern California or
University of California, Berkeley. Local anesthesia with topical
0.5% proparacaine hydrochloride ophthalmic solution (Bausch &
Laumb, Rochester, NY) and general anesthesia using a mixture of
ketamine, xylazine, and acepromazine (50 mg, 10 mg, and 1 mg/
kg body weight, respectively) were administered for each surgical
procedure.
In vivo imaging and gonioscopic examination
In vivo imaging of mice was performed as we reported recently
[16]. Digital brightfield and fluorescent micrographs of the Prox-
1
+ structures were taken using an advanced and customized
imaging system consisting of Zeiss Axio zoom V.16 (Carl Zeiss
AG, Gottingen, Germany) and an adjustable eye and head stage
holder. This non-contact imaging system with large stereomicro-
scope field of view allowed for imaging of whole cornea in separate
brightfield and fluorescence contrast. Z-stack image captures were
processed with Helicon Focus imaging software (Heliconsoft Ltd.)
to obtain extended focus images with increased depth of field.
Additionally, utilizing this system in conjunction with a specialized
2.0 mm mouse gonioprism (Ocular Instruments, Bellevue, WA)
allowed for in vivo non-invasive brightfield and fluorescent
microscopic imaging of the iridocorneal angle of the anterior
chamber [18]. The experiment was repeated at least twice with six
mice included in the study.
Electron microscopy
Eyeballs were sectioned with anterior angle intact and fixed in
2% glutaraldehyde 0.1M sodium cacodulate buffer. Tissues were
then post-fixed with 1% osmium tetroxide followed by incubation
with 0.5% aqueous uranyl acetate. Samples were dehydrated with
series of increasing acetone concentration followed by resin
embedding. Tissue blocks from 3 to 5 different locations were
sectioned and mounted on copper grids. After staining with uranyl
acetate and led citrate, samples were imaged with Tecnai 12
transmission electron microscope (FEI, Hillsboro, OR).
Suture-induced inflammatory lymphangiogenesis
The standard suture placement model with 11-0 nylon sutures
(AROSurgical, Newport Beach, CA) was used to induce corneal
inflammatory lymphangiogenesis, as reported previously
[19,20,21]. Sutures were placed intrastromally without penetrating
into the anterior chamber. The experiment was repeated twice
with four Prox-1-GFP transgenic mice included in the study.
Immunohistochemical assays and epifluorescent and
confocal microscopy
The experiments were performed similarly as reported previ-
ously [19,20]. Briefly, 1% paraformaldehyde or acetone was used
for tissue fixation. Cryosections of eyeballs or whole-mount full
thickness tissues were blocked in 10% donkey serum and
immunostained with one or two of the following antibodies:
LYVE-1 (Abcam, Cambridge, MA), alpha smooth muscle actin
(aSMA, Abcam), CD31 (BD Pharmingen, San Jose, CA), Prox-1
(AngioBio, Del Mar, CA), and VE-cadherin (Abcam). Samples
were visualized by subsequent staining with FITC and/or Cy-3
conjugated donkey anti-rabbit and/or anti-rat antibodies (Jackson
ImmunoResearch Laboratories, West Grove, PA). Samples were
covered with Vector Shield mounting medium (Vector Laborato-
ries, Burlingame, CA) and examined by an AxioImager M1
epifluorescence deconvolution microscope with AxioVision 4.8
software (Carl Zeiss AG, Go ¨ttingen, Germany). In addition,
whole-mount corneal samples together with the limbal area were
evaluated with a LSM 780 NLO AxioExaminer confocal
microscope (Carl Zeiss AG), and z-stack images were processed
with NIH Image-J and Imaris processing software to generate
three-dimensional images and videos (Bitplane, Zurich, Switzer-
land) [22]. The experiment was repeated at least three times with
eight Prox-1 transgenic and six wildtype eyes from adult mice. An
additional six eyes at the postnatal age of 3 weeks were used for
developmental analysis.
Results
High Prox-1 GFP expression at the iridocorneal angle
Our initial in vivo microscopic survey of the adult Prox-1-GFP
transgenic mouse eye revealed a large continuous band of Prox-1
expression near the corneal limbus (Figure 1A). The in vivo
diameter of this band was larger than that of the limbal or
conjunctival lymphatic vessels. Further ex vivo examination
confirmed there were two distinct Prox-1
+ structures around the
limbal area (Figure 1B and 1C). The first and more superficial
structure belonged to limbal lymphatics at the ocular surface. The
second and deeper structure ran along the iridocorneal angle
where the cornea and the iris met. Since both trabecular
meshwork and Schlemm’s canal are anatomically located at this
angle, our findings suggested that this deeper Prox-1
+ structure
was most likely either the trabecular meshwork or Schlemm’s
canal.
Gonioscopic examination of the iridocorneal angle
As shown in Figure 2, additional evaluation of the iridocorneal
angle was performed with in vivo gonioscopic examination using a
specialized mouse gonioprism. As shown in Figure 2A and 2B,
Schlemm’s Canal Live Imaging in Prox-1-GFP Mouse
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unobstructed view of the iridocorneal angle. Prox-1
+ expression
was detected at the angle in areas absent of iris processes (IP),
which were bands of pigmented tissue extending from the iris and
bridging over the angle structure.
Electron microscopic examination of the Schlemm’s
canal
It has been shown that the Prox-1-GFP mice faithfully
recapitulate the expression pattern of Prox-1 in cells and structures
without causing morphological change [15]. This is also confirmed
by our electron microscopic examination of the Prox-1-GFP mice
where normal and typical morphology of Schlemm’s canal and
trabecular meshwork was observed, as shown in Figure 3. While
the outer wall of Schlemm’s canal was lined with a monolayer of
endothelial cells, typical giant vacuoles were seen on the inner wall
protruding from the trabecular meshwork where characteristic
intertrabecular spaces were observed.
Figure 1. Brightfield and fluorescent microscopic evaluation of
the anterior segment of adult Prox-1 GFP transgenic mouse
eye. (A) In vivo profile view. Left, brightfield; Middle, green
fluorescence; Right, merged image. Prox-1
+ conjunctival (white arrows)
and limbal vessels (white arrowheads) are visible. A broad, continuous
structure (red arrowheads) expressing Prox-1 was also detected near
the limbal area. (B) Frontal view of an ex vivo Prox-1 GFP mouse cornea
together with the limbal area. White arrows: Prox-1
+ conjunctival
lymphatic vessels. (C) Enlarged view of boxed regions in (B). White
arrowheads: Prox-1
+ limbal lymphatic vessels. Red arrowheads: Prox-1
+
structure located deeper at the iridocorneal angle of the anterior
chamber. Green: Prox-1. Scale bars, 500 mm (A); 200 mm (B); 100 mm (C).
doi:10.1371/journal.pone.0098245.g001
Figure 2. In vivo gonioscopic evaluation of adult Prox-1 GFP mouse eye. (A) Gonioscopic view of the iridocorneal angle of the anterior
chamber. Direct view of the angle showing the Prox-1
+ structure (red arrowheads) in areas where pigmented iris processes (white arrows) were
absent. Left, brightfield; Middle, green fluorescence; Right panels: merged image. (B) Enlarged image of boxed area in (B). Green: Prox-1. Scale bars,
200 mm (A, B); 100 mm (C). Co, cornea; Cj, conjunctiva; I, iris; IP: iris processes.
doi:10.1371/journal.pone.0098245.g002
Figure 3. Ultrastructure electron micrographs of Schelmm’s
canal in Prox-1 GFP mice. (A) Representative image showing normal
morphology of Schlemm’s canal (SC) and nearby trabecular meshwork
(TM) in adult mice. (B) Magnified left boxed region in (A) of TM with
characteristic intertrabecular spaces (asterisks). (C) Magnified right
boxed region in (A) showing outer wall of Schlemm’s canal lined with
endothelial cells (arrow). A typical giant vacuole (arrowhead) was
observed on the inner wall of Schlemm’s canal. Scale bars, 4 mm (A);
2 mm (B, C).
doi:10.1371/journal.pone.0098245.g003
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immunohistochemical analysis
To further identify the Prox-1
+ structure at the iridocorneal
angle, we next performed a series of cross-sectional immunohis-
tochemical assays using specific antibodies against CD31, LYVE-
1, and aSMA. As illustrated by a schematic diagram of the
structures surrounding the iridocorneal angle and cross-sectional
views of the Prox-1-GFP mice, our initial examination under both
light and fluorescent microscopes showed that Prox-1 was
expressed on limbal lymphatics and the iridocorneal angle where
Schlemm’s canal was located (Figure 4A). Our additional
evaluation by a series of immunohistochemical assays further
confirmed that the Prox-1
+ angle structure was Schlemm’s canal.
It contained a typical central lumen in the shape of an elongated
ellipse and expressed CD31 (Figure 4C), a known panendothelial
cell marker present in Schlemm’s canal [23]. Moreover, this
structure was negative for aSMA expression, which was detected
in the ciliary muscle adjacent to the canal (Figure 4D). In contrast
to the high expression of LYVE-1 on Prox-1
+ limbal lymphatics,
LYVE-1 was not detected on the Prox-1
+ Schlemm’s canal
(Figure 4B). The presence of this Prox-1
+CD31
+ but LYVE-1
-
Schlemm’s canal was also confirmed in wildtype/non Prox-1-GFP
mice, as shown in Figure 5. This structure also expressed vascular
endothelial (VE) cadherin, as reported previously [23]. Addition-
ally, we have confirmed the expression pattern of Prox-1
+CD31
+
but LYVE-1
2 in the Schlemm’s canal at a developmental stage (3
weeks postnatal) in both Prox-1-GFP and wildtype mice (Figure S1
and S2) [24].
The structural morphology of Schlemm’s canal was further
examined by whole-mount tissue immunohistochemical analysis.
As shown in Figure 6A, the Prox-1
+LYVE-1
2 Schlemm’s canal
was readily distinguishable from the Prox-1
+LYVE-1
+ limbal
vessels (Figure 6A). The diameter of the Schlemm’s canal varied
along the circumference of the angle. Even at the thinnest portion
of the canal, its diameter was equal to or greater than that of the
limbal lymphatics. This confirmed our noted in vivo observation
that the annular Prox-1
+ angle structure, now identified as
Schlemm’s canal, had a larger diameter relative to conjunctival
or limbal lymphatic vessels. It was also confirmed that the limbal
lymphatics were clearly in focus and Schlemm’s canal was
defocused when focusing the microscope objective anteriorly at
the ocular surface where LYVE-1+ non-endothelial cells were also
present [12,25]. In contrast, the exact opposite was the case when
the objective was focused more posteriorly with Schlemm’s canal
in clear focus while the limbal vessels were defocused (Figure 6B).
Schlemm’s canal shows no apparent sprouting reaction
during inflammatory lymphangiogenesis from limbal
vessels
To further distinguish the two Prox-1
+ structures we identified
at the limbus and the iridocorneal angle, we assessed sprouting
reaction using the standard suture-induced inflammatory lym-
phangiogenesis model. Our results showed that after suture
placement, the Prox-1
+ limbal structure generated new lymphatic
branches (Figure S3). The newly formed lymphatics expressed
LYVE-1 (Figure 7A; 7B, left panel). In contrast, no apparent new
branches were detected from the Schlemm’s canal, which
remained LYVE-1 negative as well (Figure 7B, right panel). This
observation was also confirmed with three-dimensional rendering
of confocal z-stacks (Figure 7C, Video S1).
Discussion
To our knowledge, this study provides the first evidence
showing the high expression of the lymphatic marker Prox-1 on
Schlemm’s canal endothelium. It also provides a new method for
in vivo visualization of the canal in its entirety. Moreover, we have
shown that the Schlemm’s canal is distinguishable from typical
lymphatic endothelium by lack of LYVE-1 expression and absence
of apparent sprouting reaction when inflammatory lymphangio-
Figure 4. Cross-sectional immunohistochemical analysis of the
iridocorneal angle of adult Prox-1-GFP mice. (A) Left panel,
illustrative diagram of anterior chamber angle showing location of
Schlemm’s canal (green) at the corneoscleral junction. Yellow, limbal
lymphatic vessels; Middle to right panels: brightfield, green fluorescent,
and merged micrographs corresponding to the boxed region of interest
in the diagram. The boxed region in the diagram is on different scale for
illustrative purpose. White asterisks: limbal lymphatics; Red asterisks:
Schlemm’s canal. (B) Representative images showing the LYVE-1
+Prox-
1
+ limbal lymphatic vessel (white asterisk) located between the cornea
and conjunctiva, and the LYVE-1
2Prox1
+ Schlemm’s canal (red asterisk)
located nearby. Blue: DAPI for nuclear staining; Red: LYVE-1; Green:
Prox-1. (C) Representative images showing both limbal lymphatics
(white asterisk) and the Schlemm’s canal (red asterisk) expressed CD31,
a panendothelial cell marker. Blue: DAPI; Red: CD31; Green: Prox-1. (D)
Representative images showing aSMA was not expressed on the Prox-
1
+ Schlemm’s canal (red asterisk), but on adjacent positive control tissue
of the ciliary body. DAPI: blue; Red: aSMA; Green: Prox-1. Scale bars,
50 mm (A–D). SC, Schlemm’s canal; Co, cornea; Cj, conjunctiva; I, iris; CB:
ciliary body.
doi:10.1371/journal.pone.0098245.g004
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model used in this study is a relatively mild stimulus of
inflammation. It offers us an ideal tool to identify the difference
between limbal lymphatics and Schlemm’s canal. It is possible that
alternative methods with more robust stimulation may induce
sprouting from the Schlemm’s canal, which warrants further
investigation.
In a previous ex vivo study on human donor eyes, it was
indicated that lymphatic markers of Prox-1, LYVE-1 and
podoplanin were not expressed in the Schlemm’s canal [26]. In
the current mouse study, we detected negative expression of
LYVE-1 and podoplanin (data not shown) but positive expression
of Prox-1 both in vivo and ex vivo. The in vivo live imaging
technique has many advantages over ex vivo analysis. It allows for
direct detection and visualization of the Prox-1
+ structure at its
natural location and physiological state. This in vivo method also
eliminates possible morphological change or structural damage
with ex vivo assays that require multiple processes of tissue
sampling, fixation, and staining [16]. The current study should
therefore provide more direct and accurate information on the
expression pattern of Prox-1 in Schlemm’s canal. Nevertheless, it is
yet to be determined whether there is a discrepancy between Prox-
1 expression in human and mouse Schlemm’s canal, which is an
unlikely case based on multiple studies on Prox-1 in other tissues
and sites.
The significance of the study is threefold. First, the new finding
that Schlemm’s canal endothelium expressed a lymphatic specific
marker further suggests its closer similarities with lymphatic
endothelium than with blood endothelium. As summarized in
Table 1 [6,13,23,25]
all three types of endothelium are known to express CD31
[23,27]. However, the morphology of the canal endothelium more
resembles that of the lymphatic endothelium in that they both
have a discontinuous basement membrane with similar extracel-
lular matrix support structures [3]. Interestingly, it is commonly
accepted that both endothelia have similar vascular origins, with
both differentiating from preexisting blood vascular endothelial
cells during development [4,6,7]. There has been no evidence till
now that the canal expresses a lymphatic specific marker. It is
important to emphasize that the expressed marker, Prox-1, is a
master control gene shown to drive the vascular endothelial
differentiation into the lymphatic phenotype during development
and maintain this phenotype during maturity. Understanding
what role Prox-1 plays during the development and maintenance
of the Schlemm’s canal endothelium will be invaluable to our
better understanding of this unique structure. It is possible that the
vascular endothelial cells of the Schlemm’s canal is programmed
for Prox-1 expression as other typical lymphatics but is somehow
arrested for subsequent expression of other lymphatic markers,
such as LYVE-1, to achieve its unique features and distinctive
functions in the outflow pathway, which requires further
exploration.
Secondly, the panel of protein markers used in this study will
allow researchers to better identify, isolate, and characterize
Schlemm’s canal endothelium. For example, research with
Schlemm’s canal endothelium has lagged behind that of trabecular
meshwork cells due to lack of a distinguishing protein marker [28].
Our results suggest that sorting for CD31
+, Prox-1
+, and Lyve-1
2
cells should provide a homogeneous population of Schlemm’s
Figure 5. Cross-sectional immunohistochemical analysis of the
iridocorneal angle of adult wildtype mice. (A) Representative
images showing that Schlemm’s canal (red asterisk) is Prox-1
+ and
CD31
+. Blue: DAPI for nuclear staining; Red: Prox-1; Green: CD31. (B)
Representative images showing CD31
+ Schlemm’s canal (red asterisk) is
LYVE-1
2. Blue: DAPI; Red: LYVE-1; Green: CD31
+.( C) Representative
images showing VE-cadherin was expressed on the CD31
+ Schlemm’s
canal (red asterisk). DAPI: blue; Red: VE-cadherin; Green: CD31. Scale
bars, 50 mm (A–C). SC, Sclemm’s canal; Co, cornea; Cj, conjunctiva.
doi:10.1371/journal.pone.0098245.g005
Figure 6. Whole-mount immunohistochemical analysis of the
Prox-1
+ structures in normal adult mice. (A) Micrograph of
approximately 1/3 of the limbus (demarcated by dashed white line)
showing the location and continuity of Prox-1
+LYVE-1
2 Schlemm’s
canal. (B) Magnified view of boxed area in (A). Top panel micrographs
were taken with microscope objective anteriorly focused on Prox-
1
+LYVE-1
+ limbal lymphatic vessels (demarcated by dashed white line).
The posterior Prox-1
+LYVE-1
2 Schlemm’s canal was defocused. Bottom
panel micrographs were taken with microscope objective posteriorly
focused on the Prox-1
+LYVE-1
2 Schlemm’s canal. The limbal lymphatic
vessel was defocused. Red: LYVE-1; Green: Prox-1. Scale bars, 200 mm
(A); 100 mm (B).
doi:10.1371/journal.pone.0098245.g006
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+ structures during corneal inflammatory lymphangiogenesis. (A) Epifluorescent
micrograph showing sprouting lymphatic vessels into the inflamed cornea 2 weeks after suture placement. White dashed line: the limbus. Yellow
arrowheads: newly formed lymphatics emanating from the limbus and growing into central cornea. (B) Confocal micrographs of boxed region in (A)
showing differential sprouting reaction of the two Prox-1
+ structures located at the limbus and the angle, respectively. Left panel: anterior projection
of the confocal z-stack showing Prox-1
+LYVE-1
+ limbal (white arrowhead) and newly formed corneal lymphatic vessels (yellow arrowheads). Dashed
white line: the limbus. Right panel: posterior projection of the confocal z-stack where Prox-1
+ LYVE-1
2Schlemm’s canal was located. No apparent
sprouting reaction, or newly formed vessels were detected. (C) Images captured from 3-dimensional rendering of (B) with 0u,4 5 u,9 0 u, and 175u
rotation around the central vertical axis. Green: Prox-1; Red: LYVE-1. Scale bar: 100 mm (A–C).
doi:10.1371/journal.pone.0098245.g007
Table 1. Expression of Endothelial Cell Markers [6,13,23,25].
Endothelium Cell Type
Marker Blood Lymphatic Schlemm’s Canal
CD31 ++ +
Prox-1 - ++
LYVE-1 - + -
(+) sign indicates positive expression and (2) means no detectable expression.
doi:10.1371/journal.pone.0098245.t001
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will simplify the exclusion criteria currently used for sorting
Schlemm’s canal endothelial cells and will result in better
endothelial cell harvesting efficiency.
Lastly, we have provided a new model for Schlemm’s canal
research with the Prox-1-GFP transgenic mouse. Needless to say,
live imaging has many advantages over conventional ex vivo
investigation with dead tissues. This in vivo model for visualizing
and studying Schlemm’s canal is a new tool that we hope will allow
researchers to study normal and pathological aqueous outflow in
real time. It should also help researchers to better understand the
canal’s relationship with the lymphatic system and to what extent
the lymphatic system determines intraocular pressure. Humans
and mice share many common features of the aqueous outflow
system more than those of rabbits and primates [29]. Thus, we
believe that there is great potential that novel findings arising from
this mouse model will someday translate into human clinical
therapy for the treatment of ocular diseases associated with
aqueous outflow, most importantly glaucoma.
Supporting Information
Figure S1 Cross-sectional immunohistochemical analy-
sis of the iridocorneal angle of 3 week-old Prox-1 GFP
mice. (A) Representative images showing the Prox1
+LYVE-
1
2Schlemm’s canal (red asterisk) at the corneal scleral junction.
Blue: DAPI for nuclear staining; Red: LYVE-1; Green: Prox-1. (B)
Representative images showing both limbal lymphatics (white
asterisk) and Schlemm’s canal (red asterisk) expressed CD31. Blue:
DAPI; Red: CD31; Green: Prox-1. Scale bars, 50 mm (A and B).
SC, Schlemm’s canal; Co, cornea; Cj, conjunctiva.
(TIF)
Figure S2 Cross-sectional immunohistochemical analy-
sis of the iridocorneal angle of 3 week-old wildtype mice.
(A) Representative images showing that Schlemm’s canal (red
asterisk) is Prox-1
+ and CD31
+. Blue: DAPI for nuclear staining;
Red: Prox-1; Green: CD31. (B) Representative images showing
CD31
+ Schlemm’s canal (red asterisk) is LYVE-1
2. Blue: DAPI;
Red: LYVE-1; Green: CD31
+. Scale bars, mm (A and B). SC,
Schlemm’s canal; Co, cornea; Cj, conjunctiva.
(TIF)
Figure S3 Fluorescent microscopic evaluation of sprout-
ing lymphatic vessels into inflamed Prox-1 GFP mouse
cornea after suture placement. (A) Frontal view of the whole
cornea showing lymphatic vessels encroaching towards the center.
(B) Magnified view of boxed region in (A) showing that corneal
lymphatics are emanating from limbal lymphatics. Yellow and
white arrowhead corresponds to corneal and limbal lymphatics,
respectively, in (A, C). (C) Side view of cornea providing further
evidence that corneal lymphatics are sprouting from limbal vessels
but not the more posterior Prox-1
+ Schlemm’s canal. Green: Prox-
1. Scale bars, 500 mm (A); 250 mm (B and C).
(TIF)
Video S1 Three-dimensional rotational view of irideo-
corneal angle together with the limbal area showing
apparent sprouting of new lymphatic vessels from
limbal lymphatics but not from Schlemm’s canal. Green:
Prox-1; Red: LYVE-1. Scale bar: 100 mm.
(WMV)
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